← Back to guidelines
Oncology830 papers

Squamous cell carcinoma of cervix

Last edited: 4/10/2026

Overview

Cervical cancer (CC) is the fourth most common cancer and cause of mortality in women globally, strongly associated with high-risk human papillomavirus (HPV) infection 1. Implementation of HPV vaccination and screening programs has led to significant reductions in CC incidence in high-income countries 13.

Diagnosis

  • No specific diagnostic criteria, tests, or grading are detailed in the provided abstracts.
  • Management

  • For early-stage CC, primary treatment is surgery or radiotherapy 1.
  • For early-stage tumors with local risk factors, brachytherapy can be a preoperative option 2.
  • Postoperative radiotherapy is indicated based on histopathological criteria 2.
  • Concurrent chemoradiotherapy (CRT) is the conventional approach for locally advanced stages 1.
  • For advanced local tumors, CRT is the standard treatment, followed by a brachytherapy boost 2.
  • In recurrent or metastatic CC, immunotherapy combined with chemotherapy (with or without bevacizumab) in the first line, and as monotherapy in the second line after platinum-based chemotherapy, has improved overall survival 1.
  • Special Populations

  • No information is provided on special populations.
  • Key Recommendations

  • Concurrent chemoradiotherapy (CRT) is the conventional approach in locally advanced stages of cervical cancer 1. (Evidence: Moderate)
  • For advanced local tumors, chemoradiation is the standard treatment, followed by a brachytherapy boost 2. (Evidence: Moderate)
  • The incorporation of immunotherapy in combination with chemotherapy (with or without bevacizumab) in first line and as monotherapy in second line after platinum-based chemotherapy has significantly increased overall survival in recurrent or metastatic CC 1. (Evidence: Strong)
  • References

    1 Manso L, Ramchandani-Vaswani A, Romero I, Sánchez-Lorenzo L, Bermejo-Pérez MJ, Estévez-García P et al.. SEOM-GEICO Clinical Guidelines on cervical cancer (2023). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024. link 2 Chargari C, Peignaux K, Escande A, Renard S, Lafond C, Petit A et al.. Radiotherapy of cervical cancer. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique 2022. link 3 . Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstetrics and gynecology 2016. link

    Original source

    1. [1]
      SEOM-GEICO Clinical Guidelines on cervical cancer (2023).Manso L, Ramchandani-Vaswani A, Romero I, Sánchez-Lorenzo L, Bermejo-Pérez MJ, Estévez-García P et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
    2. [2]
      Radiotherapy of cervical cancer.Chargari C, Peignaux K, Escande A, Renard S, Lafond C, Petit A et al. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique (2022)
    3. [3]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG